Stock screenerAll disclosures →
EDGAR →
INKT
Conviction 3HealthcareScan · Mon, Aug 10, 2026INKT$10.75-1.83%
ResistanceSupportVol 14Insider sell2
Vol MA14 9.21K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price10.75
Change-1.83%
Gap-1.83%
Rel volume0.10×
Avg volume9.94K
Avg $ vol108.11K
SMA 2010.81
SMA 5011.43
SMA 20011.57
Price vs 50-5.92%
Price vs 200-7.11%
MA stackbearish
50/200 cross—
Supertrendup · 9.84
RSI (14)47
MACD hist0.07
MACD crossbull · 5d
Stoch %K / %D31 / 39
ADX (14)19
+DI / −DI25 / 14
RSI divergence—
MACD divergence—
ATR %+5.44%
ADR %4.82%
52w high17.50
52w low8.56
From 52w high-38.57%
Above 52w low+25.58%
New 52w highNo
SqueezeOn · 15d
Bollinger width13.10%
%B0.46
Donchian pos30.68%
Donchian high11.97
Donchian low10.21
AVWAP (52w high)13.72
vs AVWAP high-21.67%
AVWAP (52w low)11.61
vs AVWAP low-7.39%
OBV trendFlat
Chaikin MF (20)-0.17
Today vs 20d0.10×
Avg vol (14d)9.21K
Avg vol (20d)9.94K
Avg $ vol (20d)108.11K
Market cap53.56M
RS 3m (vs SPY)-7.84%
RS 6m (vs SPY)-14.75%
RS line new highNo
Trend template0/8
Technical rank24.9
1 week+0.56%
1 month-2.71%
3 months-2.63%
6 months-2.01%
1 year-15.09%
YTD-3.33%
P/E-4.29
P/B-4.22
P/S—
P/FCF-8.93
EPS-2.93
Div yield—
ROE98.49%
ROA-120.40%
Debt/Eq—
Current1.38
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-15.85%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value44.03M
Revenue—
Net income-2.74M
Gross profit—
Free cash flow-6M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out4.98M
Employees15
ListedFri, Oct 15, 2021
Free float1.16M
Float %24.8%
Short interest99.57K
Days to cover6.8d
Short volume34.0%
Squeeze score42 / 100
Next earningsThu, Aug 13, 2026 · pre-mkt (3d)
EPS forecast−$0.60 · 1 est
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction3 / 100
Pattern quality—
Tech rank24.9 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance12.37
Support10.32
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in INKT
No recent disclosed trades by Congress in INKT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in INKT · 7 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Ryan Barbara Director · Common Stock · 2026-06-04 | Sell | 1K | $13K | 2026-06-04 | 2026-06-05 |
Ryan Barbara Director · Common Stock · 2026-06-04 | Sell | 500 | $6K | 2026-06-04 | 2026-06-05 |
Behner Peter Director · Common Stock · 2026-06-01 | Grant | 1.31K | $16K | 2026-06-01 | 2026-06-02 |
Holcomb John Bradley Director · Common Stock · 2026-06-01 | Grant | 1.09K | $14K | 2026-06-01 | 2026-06-02 |
Ryan Barbara Director · Common Stock · 2026-06-01 | Grant | 1.43K | $18K | 2026-06-01 | 2026-06-02 |
Corvese Brian Director · Common Stock · 2026-06-01 | Grant | 1.44K | $18K | 2026-06-01 | 2026-06-02 |
WIINBERG ULF Director · Common Stock · 2026-06-01 | Grant | 1.13K | $14K | 2026-06-01 | 2026-06-02 |
WIINBERG ULF Director · Common Stock · 2026-03-02 | Other | — | — | 2026-03-02 | 2026-06-02 |
WIINBERG ULF Director · Common Stock · 2026-03-02 | Grant | 1.28K | $14K | 2026-03-02 | 2026-06-02 |
Ryan Barbara Director · Common Stock · 2026-03-02 | Grant | 1.63K | $18K | 2026-03-02 | 2026-06-02 |
SEC filings
EDGAR filings in INKT · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.